Harrow's Focus - Reviving Old Drugs In A Crowded Market
Harrow's products compete against established generics, and it heavily relies on marketing and sales force expansion to drive ...
Morningstar20d
Bausch + Lomb's stock soars 14% on report company is considering selling itself
Bausch + Lomb is headed by Brent Saunders, a longtime pharmaceutical executive known for leading Allergan into a much ... antitrust issues given its Restasis has a 45% share of the prescription ...
Yahoo Finance25d
Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
Allergan Aesthetics intends to develop onabotulinumtoxinA treatment for MMP in additional global markets and expand the use of BOTOX ® Cosmetic in the lower face. IRVINE, Calif., Sept.
BioSpace25d
Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
IRVINE, Calif., Sept. 11, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced that BOTOX ® Cosmetic (onabotulinumtoxinA) is now available for the treatment of ...